London-based Simple Life raises over €33 million in a Series B round backed by Kevin Hart to scale its AI health coach

A London-based health technology company has secured over €33 million in Series B funding, marking a significant investment in the European digital health landscape. This injection of capital signals growing investor confidence in AI-driven wellness solutions and their potential to address public health needs, particularly relevant as Europe navigates the challenges of an aging population and rising healthcare costs. The expansion of such technologies within the EU underscores the importance of data privacy and digital sovereignty in the healthcare sector. The funding round, backed by prominent investors including Hartbeat Ventures, will fuel Simple Life's growth, particularly its AI-powered health coach, "Avo." The platform boasts over 800,000 active subscribers and generated $100 million in revenue in 2024, demonstrating a 64% year-over-year increase. In a notable example of AI application, "Avo" delivered 19 million coaching messages in January, and a peer-reviewed study showed that 42% of its 50,000 users achieved at least 5% weight loss after a year, highlighting the effectiveness of AI-driven coaching. This expansion aims to advance the development of personalized wellness programs. Simple Life plans to enhance its AI capabilities through hyper-personalization, multimodal coaching, gamification, and AI-assisted content creation. This investment underscores the evolving European market's readiness to embrace technology that supports individual health and well-being, with implications for data privacy compliance under GDPR, as well as the long-term goals of digital sovereignty. This influx of funding emphasizes the growing role of AI in European healthcare. Further development and deployment of such technologies will inevitably raise questions around data security, ethical AI practices, and the potential for European alternatives to dominant global players in the digital health market.